ES2061424T3 - Metodo y composicion para determinar la actividad inmunologica de substancias bioactivas. - Google Patents

Metodo y composicion para determinar la actividad inmunologica de substancias bioactivas.

Info

Publication number
ES2061424T3
ES2061424T3 ES92920622T ES92920622T ES2061424T3 ES 2061424 T3 ES2061424 T3 ES 2061424T3 ES 92920622 T ES92920622 T ES 92920622T ES 92920622 T ES92920622 T ES 92920622T ES 2061424 T3 ES2061424 T3 ES 2061424T3
Authority
ES
Spain
Prior art keywords
bioactive substances
immunological activity
composition
balb
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92920622T
Other languages
English (en)
Spanish (es)
Other versions
ES2061424T1 (es
Inventor
Anna Inglot
Zofia Blach-Olszewska
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Torf Establishment
Original Assignee
Torf Establishment
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Torf Establishment filed Critical Torf Establishment
Publication of ES2061424T1 publication Critical patent/ES2061424T1/es
Application granted granted Critical
Publication of ES2061424T3 publication Critical patent/ES2061424T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
    • A61K35/10—Peat; Amber; Turf; Humus

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
ES92920622T 1991-10-26 1992-09-28 Metodo y composicion para determinar la actividad inmunologica de substancias bioactivas. Expired - Lifetime ES2061424T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP91118269A EP0539610A1 (en) 1991-10-26 1991-10-26 Method and composition for determining the immunological activity of solutions containing active substances

Publications (2)

Publication Number Publication Date
ES2061424T1 ES2061424T1 (es) 1994-12-16
ES2061424T3 true ES2061424T3 (es) 1997-10-01

Family

ID=8207282

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92920622T Expired - Lifetime ES2061424T3 (es) 1991-10-26 1992-09-28 Metodo y composicion para determinar la actividad inmunologica de substancias bioactivas.

Country Status (22)

Country Link
US (1) US5543300A (enExample)
EP (2) EP0539610A1 (enExample)
JP (1) JPH07500905A (enExample)
AT (1) ATE153763T1 (enExample)
AU (1) AU678343B2 (enExample)
BG (1) BG61705B1 (enExample)
CA (1) CA2122131A1 (enExample)
CZ (1) CZ100494A3 (enExample)
DE (3) DE539610T1 (enExample)
DK (1) DK0609255T3 (enExample)
ES (1) ES2061424T3 (enExample)
FI (1) FI941920A0 (enExample)
GR (3) GR930300100T1 (enExample)
HU (1) HU216863B (enExample)
LV (1) LV12140B (enExample)
NO (1) NO941444L (enExample)
PL (1) PL170592B1 (enExample)
RO (1) RO114837B1 (enExample)
RU (1) RU2125727C1 (enExample)
SG (1) SG72665A1 (enExample)
SK (1) SK44094A3 (enExample)
WO (1) WO1993008470A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19615470A1 (de) * 1996-04-19 1997-10-23 Heinz Beinio Körperpflegemittel und Verfahren zu seiner Herstellung
US6630179B1 (en) * 1998-09-23 2003-10-07 Enerkom (Proprietary) Limited Oxihumic acid and its use in the treatment of various conditions
RU2180120C1 (ru) * 2000-07-05 2002-02-27 Научно-исследовательский институт детских инфекций Способ выявления цитокинов
GB0101973D0 (en) * 2001-01-25 2001-03-14 Statens Seruminstitut Improved in vitro diagnostic method of detecting a cell-mediated immune response
RU2226275C2 (ru) * 2002-04-15 2004-03-27 Научно-исследовательский и учебно-методический центр биомедицинских технологий ВИЛАР Способ определения цитотоксического эффекта и ростстимулирующей активности веществ для доклинических испытаний
DK1449535T3 (da) * 2003-02-18 2006-09-11 Clinique La Prairie Res Sa Præparater der omfatter fötalt hæmoglobin og bakterieendotoksin samt eventuelt fötale leverbestanddele
US7497947B2 (en) 2004-04-14 2009-03-03 Embro Corporation Devices for water treatment
US7614340B2 (en) * 2007-02-09 2009-11-10 Honeywell International Inc. Composite piston housing for aircraft brakes
US9005449B2 (en) 2011-09-07 2015-04-14 Embro Corporation Use of moss to reduce disinfection by-products in water treated with disinfectants
US9795809B2 (en) 2013-12-23 2017-10-24 Embro Corporation Use of moss to improve dental health
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH636448A5 (en) * 1977-05-06 1983-05-31 Horst Veith Process for the determination of the effect of substances on constituents of the blood for the detection of infectious and immunological processes and composition for carrying it out
NZ214400A (en) * 1985-12-02 1989-05-29 Univ Otago Detecting infection in ruminant including conducting assay of mononuclear cell function
DE3782958D1 (de) * 1986-02-19 1993-01-21 Imreg Inc Verfahren und mittel zum pruefen eines immunsystems.
CA1299099C (en) * 1986-03-06 1992-04-21 Paul Richard Wood In vitro assay for detecting cell-mediated immune responses
US5096708A (en) * 1988-07-07 1992-03-17 Sven Gohla Medical preparation containing as active agent a component from thuja plants which comprises polysaccharides
WO1992016600A1 (en) * 1991-03-16 1992-10-01 Torf Establishment Process for the extraction of peat and apparatus for carrying out the process

Also Published As

Publication number Publication date
ATE153763T1 (de) 1997-06-15
ES2061424T1 (es) 1994-12-16
HK1002610A1 (en) 1998-09-04
JPH07500905A (ja) 1995-01-26
CZ100494A3 (en) 1994-11-16
GR3024457T3 (en) 1997-11-28
HUT69990A (en) 1995-09-28
BG61705B1 (bg) 1998-03-31
HU9401185D0 (en) 1994-07-28
BG98720A (bg) 1995-07-28
DK0609255T3 (da) 1997-12-22
DE609255T1 (de) 1995-06-14
PL170592B1 (en) 1997-01-31
FI941920L (fi) 1994-04-25
EP0609255A1 (en) 1994-08-10
RO114837B1 (ro) 1999-07-30
DE539610T1 (de) 1993-12-16
FI941920A7 (fi) 1994-04-25
LV12140B (lv) 1998-12-20
RU2125727C1 (ru) 1999-01-27
HU216863B (hu) 1999-09-28
NO941444D0 (no) 1994-04-21
DE69220078D1 (de) 1997-07-03
SG72665A1 (en) 2000-05-23
US5543300A (en) 1996-08-06
SK44094A3 (en) 1995-03-08
RU94022481A (ru) 1996-09-27
CA2122131A1 (en) 1993-04-29
LV12140A (lv) 1998-09-20
EP0539610A1 (en) 1993-05-05
FI941920A0 (fi) 1994-04-25
WO1993008470A1 (en) 1993-04-29
AU678343B2 (en) 1997-05-29
NO941444L (no) 1994-06-16
GR940300077T1 (en) 1994-11-30
DE69220078T2 (de) 1997-12-04
GR930300100T1 (enExample) 1993-10-29
EP0609255B1 (en) 1997-05-28
AU2650992A (en) 1993-05-21

Similar Documents

Publication Publication Date Title
ES2061424T3 (es) Metodo y composicion para determinar la actividad inmunologica de substancias bioactivas.
ES2094159T3 (es) Produccion de factor de crecimiento de celulas endoteliales vasculares.
IT1132101B (it) Procedimento per la produzione di etanolo in forte concentrazione impiegando microorganismi immobilizzati
GR1000039B (el) Ενεργος ειδικη ανοσοαναστολη.
ES8705036A1 (es) Procedimiento para preparar una vacuna que comprende un polipeptido fijado a una membrana
DK85786D0 (da) Biologisk aktive fragmenter af human antihaemofilisk faktor og fremgangsmaade til fremstilling deraf
DE69029257D1 (de) Anordnung zur bestrahlung von laserstrahlen
ATE111735T1 (de) Verwendung des wirkstoffs azelastin und glycerinethern zur bekämpfung von psoriasis- erkrankungen.
FI885399A7 (fi) Uusi lääkevoide, menetelmä sen valmistamiseksi, tätä lääkevoidetta käy ttämällä aikaansaadut käyttömuodot sekä niiden valmistus
ATA91797A (de) Eine das vwf-propeptid enthaltende pharmazeutische präparation
BG49827A3 (bg) Метод за получаване на пречистен биологично активен рекомбинантен човешки колоний стимулиращ фактор
ATE69953T1 (de) Verwendung von polysulfatierten heparinen.
Basch et al. Thymopoietin-induced acquisition of responsiveness to T cell mitogens
EP0837687A4 (en) HAPTEN MODIFIED TUMOR CELL EXTRACT AND METHOD FOR TREATING OR DETECTING CANCER
ES2038969T3 (es) Procedimiento para la renaturalizacion de proteinas.
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
ATE89728T1 (de) Verwendung von dihydroergotamin und seinen salzen zur lokalen behandlung trophischer stoerungen.
BR9205624A (pt) Compostos de 1,2,3,4-oxatriazol-5-imina substituída na posição 3, processo para a preparação dos mesmos e preparação farmacêutica contendo esses compostos.
Scheinberg et al. Decreased lymphocyte response to PHA, Con‐A, and calcium ionophore (A23187) in patients with RA and SLE, and reversal with levamisole in rheumatoid arthritis
NO173336C (no) Fremgangsm}te til isolering av basalmembranproteiner fra human- eller animalvev og anvendelse av det oppn}dde protein
ES2058372T3 (es) Procedimiento para la obtencion de esteres del acido 5-cloro-3-clorosulfonil-2-tiofenocarboxilico.
Kinouchi et al. Ultraviolet B irradiation increases keratin 5 and keratin 14 expression through epidermal growth factor receptor of SV40-transformed human keratinocytes
Sörbris et al. Differences in heat production between adipocytes from obese and normal weight individuals
WOLARSKY et al. Effect of chondroitin sulfate on tensile strength of healing wounds
Ahuja et al. Evaluation of low level laser therapy, platelet rich plasma, and their combination on the proliferation rate of human periodontal ligament fibroblast: an in vitro study

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 609255

Country of ref document: ES